| Dr Parul Sharma, DO | |
|
1909 214th St Se, Bothell, WA 98021-4412 | |
| (425) 412-7200 | |
| Not Available |
| Full Name | Dr Parul Sharma |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 18 Years |
| Location | 1909 214th St Se, Bothell, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093918971 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | OP60153539 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Edmonds Hospital | Edmonds, WA | Hospital |
| Swedish Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacmed Clinics | 2466350657 | 185 |
News Archive
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Long-term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a hallmark of Alzheimer's disease, and activated inflammatory microglial cells in the brains of mice in a new study by neuroscientists from the University of Chicago.
New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
› Verified 1 days ago
| Entity Name | Pacmed Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013061217 PECOS PAC ID: 2466350657 Enrollment ID: O20031226000033 |
News Archive
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Long-term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a hallmark of Alzheimer's disease, and activated inflammatory microglial cells in the brains of mice in a new study by neuroscientists from the University of Chicago.
New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Parul Sharma, DO 21401 72nd Ave W, Edmonds, WA 98026-7702 Ph: (425) 774-2636 | Dr Parul Sharma, DO 1909 214th St Se, Bothell, WA 98021-4412 Ph: (425) 412-7200 |
News Archive
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Long-term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a hallmark of Alzheimer's disease, and activated inflammatory microglial cells in the brains of mice in a new study by neuroscientists from the University of Chicago.
New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
› Verified 1 days ago
Dr. Ruth A. Freeman, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1908 201st Pl Se Ste 100, Bothell, WA 98012 Phone: 425-219-4720 Fax: 425-949-7059 | |
Shiquan Liu, MD, PHD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 10701 E Riverside Dr, Apt# 2, Bothell, WA 98011 Phone: 917-302-4077 | |
Jody M Rhoades, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1909 214th St Se, Suite 300, Bothell, WA 98021 Phone: 425-412-7200 Fax: 425-412-7281 | |
Kent William Blakely, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1909 214th St Se Ste 211, Bothell, WA 98021 Phone: 425-248-2626 | |
Dr. Kerlan Peter Wolsey, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1909 214th St Se Ste 300, Bothell, WA 98021 Phone: 425-412-7200 | |
Diane Doerner, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1909 214th St Se, Suite 211, Bothell, WA 98021 Phone: 425-420-1648 Fax: 425-420-1649 |